Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer
NCT07200141Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in rectal adenocarcinoma (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Complete Response at 1 year. Started Oct 2025; status: recruiting.
02
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT07200141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07200141.